CDK4 Expression in Chordoma: A Potential Therapeutic Target Running Title: CDK4 Expression in Chordoma

Journal of Orthopaedic Research - United States
doi 10.1002/jor.23819
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2020English

Sacral Chordoma

Radiographics
MedicineNuclear MedicineRadiologyImaging
2009English

MicroRNA-155 Expression Is Independently Predictive of Outcome in Chordoma

Oncotarget
Oncology
2015English

CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs.

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

CDK4 as a Phytochemical Based Anticancer Drug Target

2019English

Chordoma in a Thoracic Vertebra

Acta Radiologica
1941English

Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma

Veterinary Pathology
Veterinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy